(Q37614318)

English

Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development

scientific article published on 14 October 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1 reference

Europe PubMed Central

Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

experimental autoimmune encephalomyelitis

0 references

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

author name string

Yolanda S Kap

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Jon D Laman

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Bert A 't Hart

3

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

publication date

14 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Journal of Neuroimmune Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

220-230

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule

1 reference

https://api.crossref.org/works/10.1007%2FS11481-009-9178-Y

21 January 2018

Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1007%2FS11481-009-9178-Y

21 January 2018

Of mice and not men: differences between mouse and human immunology

1 reference

https://api.crossref.org/works/10.1007%2FS11481-009-9178-Y

21 January 2018

Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithr

1 reference

https://api.crossref.org/works/10.1007%2FS11481-009-9178-Y

21 January 2018

B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse cortical atrophy in a marmoset model of multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MRI-guided immunotherapy development for multiple sclerosis in a primate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functions of CD40 and its ligand, gp39 (CD40L).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical models of multiple sclerosis in nonhuman primates

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulins and complement in postmortem multiple sclerosis tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with chimeric anti-human CD40 antibody suppresses MRI-detectable inflammation and enlargement of pre-existing brain lesions in common marmosets affected by MOG-induced EAE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional role of CD40 and its ligand

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EBV in MS: guilty by association?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of animal models for drug development in multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can the pharmaceutical industry reduce attrition rates?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure is an option: learning from unsuccessful proof-of-concept trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling of multiple sclerosis: lessons learned in a non-human primate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The trials and errors in MS therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Demyelination and axonal damage in a non-human primate model of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental models of spontaneous autoimmune disease in the central nervous system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grey matter pathology in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19826959

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11481-009-9178-Y

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37614318&oldid=2235858614"